Brainomix and 3DR Labs have announced a new strategic partnership to support acute stroke care in the USA through the clinically validated and US Food and Drug Administration (FDA)-cleared Brainomix 360 Stroke platform.
Brainomix claims that its artificial intelligence (AI)-powered 360 Stroke imaging tool is the only technology of its kind to have demonstrated an impact on stroke treatment rates, with results from a large real-world evaluation indicating a >50% increase in mechanical thrombectomy rates where the company’s software was clinically adopted.
3DR Labs specialises in high-quality 3D and advanced post-processing services for medical imaging, as well as clinical AI workflow solutions. With a team of more than 250 certified and registered radiologic technologists, the company delivers complex image reconstructions quickly, accurately and cost-effectively to aid radiologists, radiologic technologists and clinicians.
This partnership is said to complement the recent launch of 3DR Labs’ Neurology Center of Excellence—a dedicated division focused on providing specialised post-processing services for stroke, presurgical planning, and the management of brain and spine diseases. The centre is staffed by highly trained radiologic technologists who have achieved 3DR’s proprietary Code Stroke Certification, ensuring consistent quality and clinical expertise in neuroimaging, according to a joint press release from Brainomix and 3DR Labs.
“We are delighted to announce this partnership with 3DR Labs across the USA, who have an impressive track record of providing best-in-class products and service for their customers,” said Michalis Papadakis, chief executive officer (CEO) and co-founder of Brainomix. “Our teams now have an opportunity to deliver a comprehensive and seamless solution that can help stroke teams optimise the delivery of the care they provide to patients.”
“Our collaboration with Brainomix enhances the ability to quickly and accurately assess patient eligibility for interventions like thrombectomy based on stroke severity,” added Rob Falk, founder and chief medical officer of 3DR Labs. “Together, we are delivering a streamlined, all-in-one stroke solution for radiology and neurology teams.”
